| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $243.2M | $243.2M | $235.1M |
| YoY Revenue Growth % | 0.0% | +3.4% | — |
| Gross Profit | $179.4M | $174.6M | — |
| Gross Margin % | 73.8% | 71.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $48.4M | $44.8M | -$28.9M |
| Operating Margin % | 19.9% | 18.4% | -12.3% |
| Net Income (GAAP) | $72.9M | $57.1M | -$29.8M |
| EBITDA (Normalized) | $55.6M | $52.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $59.5M | $55.7M | -$10.7M |
| Capital Expenditures (CapEx) | $9.0M | $9.2M | — |
| Free Cash Flow (FCF) | $50.5M | $46.4M | -$10.7M |
| FCF Margin % | 20.8% | 19.1% | -4.6% |
| Return on Invested Capital (ROIC %) | 19.0% | 27.4% | — |
| Cash & Short-Term Equivalents | $70.5M | $83.2M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $271.8M | $212.5M | — |